Authors

  1. Vander Vegt, Christina B. PhD
  2. Hill-Pearson, Candace A. BSN
  3. Hershaw, Jamie N. PhD
  4. Loftin, Megan C. MS
  5. Bobula, Selena A. DPT
  6. Souvignier, Alicia R. DPT

Abstract

Objective: To compare clinical outcomes between active duty service members receiving generalized versus individualized vestibular rehabilitation treatment (GVRT and IVRT, respectively) for persistent vestibular-related symptoms following mild traumatic brain injury (mTBI).

 

Setting: An outpatient TBI rehabilitation clinic.

 

Participants: Fifty-seven participants with persistent vestibular-related symptoms following mTBI were randomly assigned to the GVRT (n = 28) or IVRT (n = 29) group, stratified by dizziness-related impairment severity. Forty-two participants (n = 21 per group) completed the posttreatment evaluation and were included in analyses.

 

Design: We employed a single-site, randomized, pre-/posttest experimental design. The GVRT program consisted of eight 45-minute group-based treatment sessions and IVRT consisted of three 30-minute one-on-one treatment sessions both to be completed within 8 weeks. Group assignment was not blinded to study personnel or participants. Research evaluations were completed approximately 2 weeks prior to treatment initiation and following treatment completion.

 

Main Measures: Outcome measures included Dizziness Handicap Inventory (DHI) and Activities-specific Balance Confidence Scale (ABC) total scores, Sensory Organization Test (SOT) composite equilibrium and sensory input ratio scores, Head Shake SOT (HS-SOT) conditions 2 and 5, and horizontal and vertical Dynamic Visual Acuity. Separate mixed-effects models were used to compare clinical outcomes between the GVRT and IVRT groups.

 

Results: Both groups demonstrated significant improvement from pre- to posttreatment on self-reported dizziness-related impairment (DHI [F(1,41) = 16.28, P < .001]) and balance performance with and without head movement (composite equilibrium score [F(1,41) = 16.58, P < .001, effect size [ES] = 0.43], somatosensory [F(1,41) = 6.79, P = .013, ES = 0.26], visual [F(1,41) = 6.49, P = .015, ES = 0.29], vestibular [F(1,41) = 22.31, P < .001, ES = 0.55], and HS-SOT condition 5 [F(1,38) = 23.98, P < .001, ES = 0.64]). Treatment effects did not differ between groups on any of the outcome measures.

 

Conclusions: We provide preliminary evidence that differences in clinical outcomes do not exist between participants receiving generalized versus individualized VR. Further research is needed to determine comparative effectiveness between these 2 treatment approaches for persistent vestibular-related symptoms following mTBI.